ICU Medical’s Acquisition of Smiths Medical Could Create New Powerhouse in Infusion, Says Signify Research
Published: February 28, 2022
25th February 2022 – Written by Kelly Patrick – ICU Medical Inc. (San Clemente, CA, USA) has completed its acquisition of Smiths Medical (Minneapolis, MN, USA) from Smiths Group plc., creating a new powerhouse in infusion, according to Signify Research (Cranfield, UK), an independent supplier of market intelligence and consultancy to the global healthcare technology industry.
The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products. The acquisition aims to support the expansion of ICU Medical’s infusion therapy product line and expand the portfolio into newer clinical care markets. When combined with ICU Medical’s existing businesses, the combined companies create a leading infusion therapy company with estimated pro forma combined revenues of approximately USD 2.5 billion.
Click here to continue reading on HospiMedica’s website….Share on LinkedIn
Clinical Care DevicesPublished March 2021
Clinical Care Devices
This is Signify Research’s 2021 report on the Clinical Care Devices Market, which was published in March 2021.
Find out more